HC Wainwright & Co. Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $4
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Vernon Bernardino maintains a Buy rating on TFF Pharmaceuticals (NASDAQ:TFFP) but lowers the price target from $22 to $4.
May 25, 2023 | 10:11 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. maintains a Buy rating on TFF Pharmaceuticals but lowers the price target from $22 to $4.
The news of HC Wainwright maintaining a Buy rating on TFF Pharmaceuticals is positive for the stock. However, the lowering of the price target from $22 to $4 may create uncertainty among investors, potentially offsetting the positive sentiment. As a result, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100